Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study

Background Accurate staging of patients with gastric cancer is necessary for selection of the most appropriate and personalized therapy. Computed tomography (CT) is currently used as primary staging tool, being widely available with a relatively high accuracy for the detection of parenchymal metastases, but with low sensitivity for the detection of peritoneal metastases. Magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI) has a very high contrast resolution, suggesting a higher diagnostic performance in the detection of small peritoneal lesions. The aim of this study was to retrospectively evaluate the added value of whole-body diffusion-weighted MRI (WB-DWI/MRI) to CT for detection of peritoneal carcinomatosis (PC) and distant metastases in the preoperative staging of gastric cancer. Methods This retrospective study included thirty-two patients with a suspicion of gastric cancer/recurrence, who underwent WB-DWI/MRI at 1.5 T, in addition to CT of thorax and abdomen. Images were evaluated by two experienced abdominal radiologists in consensus. Histopathology, laparoscopy and/or 1-year follow-up were used as reference standard. Results For overall tumour detection ( n  =  32 ), CT sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) was 83.3%, 100%, 100% and 82.4% respectively. For WB-DWI/MRI these values were 100%, 92.9%, 94.7% and 100%, respectively. For staging ( n  =  18 ) malignant lymph nodes and metastases, CT had a sensitivity, specificity/PPV/NPV of 50%/100%/100%/71.4%, and 15.4%/100%/100%/31.3% respectively. For WB-DWI/MRI, all values were 100%, for both malignant lymph nodes and metastases. WB-DWI/MRI was significantly better than CT in detecting tumour infiltration of the mesenteric root, serosal involvement of the small bowel and peritoneal metastases for which WB-DWI/MRI was correct in 100% of these cases, CT 0%. Conclusions WB-DWI/MRI is highly accurate for diagnosis, staging and follow-up of patients with suspected gastric cancer.

[1]  D. Cunningham,et al.  Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  R. Low,et al.  Comparison of MRI and CT for Predicting the Peritoneal Cancer Index (PCI) Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures , 2015, Annals of Surgical Oncology.

[3]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[4]  M. Soussan,et al.  Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy , 2012, European Radiology.

[5]  Dow-Mu Koh,et al.  Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[6]  F. Roviello,et al.  Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) , 2013, Abdominal Imaging.

[7]  S. Dymarkowski,et al.  Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT , 2014, European Radiology.

[8]  Rinku Sutradhar,et al.  How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis , 2012, Gastric Cancer.

[9]  F. Giganti,et al.  Esophagus and Stomach: Is There a Role for MR Imaging? , 2020, Magnetic resonance imaging clinics of North America.

[10]  Hyung Sik Kim,et al.  The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. , 2011, European journal of radiology.

[11]  F. Giganti,et al.  Gastric cancer and image-derived quantitative parameters: Part 2—a critical review of DCE-MRI and 18F-FDG PET/CT findings , 2019, European Radiology.

[12]  Yong Xu,et al.  Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy , 2011, European Radiology.

[13]  J. Costoya,et al.  Defining hypoxic microenvironments by non-invasive functional optical imaging. , 2013, European journal of cancer.

[14]  T. Chua,et al.  Determining the Association Between Preoperative Computed Tomography Findings and Postoperative Outcomes After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei , 2011, Annals of Surgical Oncology.

[15]  D. Cunningham,et al.  Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Y. McConnell,et al.  Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis. , 2014, American journal of surgery.

[17]  Maria Antonietta Mazzei,et al.  Accuracy of MDCT in the preoperative definition of peritoneal cancer index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) , 2013 .

[18]  E. Tokunaga,et al.  Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer , 2000, The British journal of surgery.

[19]  Jeong Min Lee,et al.  Prospective comparison of 3T MRI with diffusion‐weighted imaging and MDCT for the preoperative TNM staging of gastric cancer , 2015, Journal of magnetic resonance imaging : JMRI.

[20]  F. Schmidt.  Meta-Analysis , 2008 .

[21]  Kwonoh Park,et al.  Usefulness of Combined PET/CT to Assess Regional Lymph Node Involvement in Gastric Cancer , 2014 .

[22]  D. Elias,et al.  Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT , 2007, Abdominal Imaging.

[23]  F. De Keyzer,et al.  Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases , 2019, Cancer Imaging.

[24]  D. Morris,et al.  Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis , 2009, Annals of surgical oncology.

[25]  T. Kwee,et al.  Imaging in assessing lymph node status in gastric cancer , 2009, Gastric Cancer.

[26]  T. Kwee,et al.  Modern imaging techniques for preoperative detection of distant metastases in gastric cancer. , 2015, World journal of gastroenterology.

[27]  R. Malthaner,et al.  Staging and surgical approaches in gastric cancer: a clinical practice guideline. , 2017, Current oncology.

[28]  M. P. Tristan D. Yan BSc,et al.  Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis , 2008, Annals of Surgical Oncology.

[29]  F. Giganti,et al.  Gastric cancer and imaging biomarkers: Part 1 – a critical review of DW-MRI and CE-MDCT findings , 2018, European Radiology.

[30]  R. van Hillegersberg,et al.  Imaging strategies in the management of gastric cancer: current role and future potential of MRI. , 2019, The British journal of radiology.

[31]  S. Noh,et al.  Recurrence following curative resection for gastric carcinoma , 2000, The British journal of surgery.

[32]  F. De Keyzer,et al.  Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. , 2017, European journal of cancer.

[33]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[34]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[35]  P. Parrilla,et al.  Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue. , 2016, European journal of radiology.

[36]  Huilin Yang,et al.  Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT , 2017, Journal of Cancer Research and Clinical Oncology.

[37]  L. Helyer,et al.  A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer , 2012, Gastric Cancer.

[38]  R. Low.  Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. , 2016, Journal of gastrointestinal oncology.

[39]  A. Padhani,et al.  What's New for Clinical Whole-body MRI (WB-MRI) in the 21st Century. , 2020, The British journal of radiology.

[40]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[41]  D. Coit,et al.  Clinical Outcomes With Laparoscopic Stage M1, Unresected Gastric Adenocarcinoma , 2006, Annals of surgery.

[42]  K. Lee,et al.  Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. , 2009, Radiology.

[43]  J. Lee,et al.  State-of-the-art preoperative staging of gastric cancer by MDCT and magnetic resonance imaging. , 2014, World journal of gastroenterology.